Movement Alert|Core Scientific Rises 5.78% in Regular Trading, B.Riley Target Price Upgrade and Institutional Position Changes Continue to Drive Stock Higher

Market Focus06-02

On June 2, Core Scientific rose 5.78% in regular trading, trading at $30.3/share, with trading volume of approximately $77.67 million. The stock has broken through prior key price levels, reflecting sustained upward momentum.

On the news front, investment bank B.Riley recently raised the company's target price from $30 to $33 while maintaining a buy rating. The analyst consensus target price stands at $30.12, with the current share price now approaching that level after a multi-session recovery. Additionally, the company has recently filed multiple Form 4 and Schedule 13G/A documents, indicating ongoing changes in institutional investor holdings. The market interprets these filings as positive signals of capital inflows, which have jointly propelled the stock's continued advance.

Within the Application Software sector, compute-related names showed relative strength, with IREN Ltd rising 4.44%, providing sector linkage support for Core Scientific. Meanwhile, other sector constituents diverged, with Palantir down 4.1%, Strategy down 6.92%, Salesforce down 3.93%, and Intuit down 8.06%.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment